Valeant Pharma (NYSE:VRX) Intraday Stock Chart LAVAL, Quebec, June 17, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:... ...
http://in.advfn.com/p.php?pid=nmona&article=58029712-- 53.6 Percent Overall Response Rate and Median Duration of Response of 11.9 Months in Heavily Pre-Treated Patients -- -- Data to be Presented... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=5133&title=Gilead-Announces-Interim-Phase-2-Data-for-Idelalisib-Showing-Response-in-Refractory-Indolent-NonHodgkin’s-LymphomaApple has announced iOS7 the latest version of its operating system for its iPhones and iPads which has been described as 'the most significant iOS... ...
http://www.manoramaonline.com/cgi-bin/MMOnline.dll/portal/ep/contentView.do?contentId=14318835&tabId=1&programId=11565539&BV_ID=@@@Markets slipped into the red following dismal reports on the home front coupled with investor concerns about the future of the Federal Reserve's... ...
http://in.quote.com/news/zacksCache.aspx?id=721504India News: The Congress reshuffle comes just before the much talked about Union Cabinet reshuffle which could take place as early as Monday,... ...
http://www.keralanext.com/news/2013/06/17/article109.asp